Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reliva is a leading consumer health and wellness company specializing in high-quality, hemp-derived CBD products. Founded in 2018, the company quickly established itself as a top-selling brand in the United States, achieving significant retail distribution across more than 20,000 locations, including major pharmacy chains and convenience stores. Reliva's product portfolio includes CBD-infused gummies, topicals, tinctures, and sprays designed to address common wellness needs such as pain management, anxiety relief, and sleep support. In May 2020, Reliva was acquired by Aurora Cannabis, a global leader in the cannabis industry, to serve as its primary entry point into the U.S. CBD market. The company is recognized for its commitment to rigorous testing, quality control, and compliance with regulatory standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reliva.